Aspartylglucosaminuria

This is a rare genetic condition that affects how your body breaks down certain sugars. It's caused by a missing enzyme that helps clear out waste products from your cells. This waste builds up over time, leading to problems in the body.

Condition

What people with Aspartylglucosaminuria report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Aspartylglucosaminuria

What It Is

Aspartylglucosaminuria (AGU) is a rare inherited condition that mainly affects learning, speech and movement, and that slowly progresses over a lifetime. It is a lysosomal storage disorder. Lysosomes are the parts of a cell that break down and recycle used material. In AGU, an enzyme called aspartylglucosaminidase is missing or barely works, so sugar-protein fragments that should be broken down build up inside cells instead. Brain cells are especially affected, but the buildup also touches bones, joints, skin, teeth and the immune system. Babies with AGU usually look healthy at birth. Early clues can include a growth spurt with a large head, hernias, and frequent ear and chest infections. Around age 2 or 3, delays in speech and coordination become noticeable, and many children are restless or hyperactive. Distinctive facial features, such as widely spaced eyes, a short broad nose and full lips, tend to become more noticeable with age. AGU is most common in Finland, but it occurs in people of every background and is probably underdiagnosed elsewhere.

Causes & Risk Factors

AGU is caused by changes (variants) in the AGA gene, named for the aspartylglucosaminidase enzyme it makes. It is inherited in an autosomal recessive pattern: a child is affected only when they inherit a non-working copy of the gene from each parent. Parents who each carry one copy are usually healthy and often have no idea they are carriers. When both parents are carriers, each pregnancy has a 25 percent (one in four) chance of a child with AGU, a 50 percent chance of a child who is a healthy carrier, and a 25 percent chance of a child who neither has AGU nor carries it. Nothing a parent did during pregnancy causes AGU, and nothing in daily life triggers it. In Finland, one specific variant accounts for almost all cases, and roughly 1 in 50 to 60 Finns carries it; elsewhere, a range of different variants is seen.

How It's Diagnosed

Because the early signs overlap with many other causes of developmental delay, AGU is often recognized only after several years. In Finland the average age at diagnosis has been about 5. Testing usually starts with a urine screen for oligosaccharides, the sugar fragments that build up and spill into the urine. An abnormal result is followed by a blood test that measures how active the aspartylglucosaminidase enzyme is; very low activity points to AGU. Genetic testing of the AGA gene confirms the diagnosis by finding a variant in both copies, and it is increasingly how AGU is found, sometimes in older children or adults tested for unexplained intellectual disability. Once a family's variants are known, younger brothers and sisters can be tested so that support starts early, relatives can learn whether they are carriers, and testing during a future pregnancy or before embryo transfer is possible. A genetic counselor can help a family work through these choices.

Treatment Options

There is currently no cure and no approved treatment that corrects the enzyme deficiency. Care aims to help each person learn and do as much as they can, and to treat the medical problems AGU causes as they appear. Bone marrow transplantation has been tried in a small number of people without clear benefit, so it is not a standard option. In childhood, early intervention, speech and occupational therapy, and special education build communication and everyday skills. Seizures, which affect about one in three people with AGU, are treated with standard seizure medicines. Behavior and sleep problems, recurring infections, gum disease and other dental problems, scoliosis, joint pain and stiffness, osteoporosis (thinning bones) and bowel problems are each managed with the usual treatments for those conditions. Adults often benefit from physical therapy and activities that keep them engaged, such as music. A care coordinator or social worker can help a family manage services across many specialists. Researchers are developing treatments that target the cause, including gene therapy, which aims to give cells a working copy of the AGA gene. These are being studied in research settings and are not yet available as routine care.

What to Expect

AGU follows a fairly recognizable course, though the pace differs from person to person and tends to be a little slower in women. Children keep learning and gaining skills, more slowly than their peers, into the early teenage years. Many go to school, become independent with dressing and toileting, and are often described as friendly and sociable. Skills then tend to level off through the late teens and twenties, with a slow decline. From about age 30, decline usually becomes faster: speech shrinks to a few words, walking and balance get harder, and people come to need help with most daily activities. Other changes build up over time, including thinning bones, curvature of the spine, stiff joints, gum disease, skin changes and, in some people, low blood counts, seizures or periods of psychiatric symptoms. Regular follow-up is designed to catch these early: development, seizures, spine, joints and infections are checked at each visit, teeth every six months, and bone density about every five years. People with AGU usually live into middle adulthood. In Finnish studies average life expectancy was about 45 for men and 50 for women, and serious lung infections were the most common cause of death. Planning ahead for education, adult services, guardianship and long-term care helps families prepare for changing needs.

When to Seek Help

Ask for an evaluation, including metabolic or genetic testing, if a child has delayed speech or coordination along with features such as an early growth spurt, a large head, hernias or frequent ear and chest infections, or if an adult has unexplained intellectual disability that seems to be worsening. Contact the care team promptly about a first seizure or a change in seizure pattern, signs of a chest infection such as fever, cough or fast or labored breathing, or a noticeable loss of skills, new behavior changes or confusion, since an illness or another treatable problem may be responsible.

Questions to Ask Your Doctor

  1. 1.Which tests confirmed the diagnosis, and should my other children or relatives be tested?
  2. 2.Which specialists should be part of the care team, and who will coordinate their care?
  3. 3.What therapies and school supports would help most at this stage?
  4. 4.What changes should we watch for over the next few years, and how will we monitor bones, teeth and blood counts?
  5. 5.Are there clinical trials or natural history studies we could consider joining?

Last reviewed • Oct 2026

Educational content, not medical advice.